
ARVINAS, INC. — Investor Relations & Filings
Arvinas, Inc. is a clinical-stage biopharmaceutical company that develops therapeutics based on targeted protein degradation. The company is a leader in this field, utilizing its proprietary PROTAC® (PROteolysis TArgeting Chimera) platform to create a new class of drugs. This technology is designed to harness the body's own cellular machinery to selectively remove disease-causing proteins. Arvinas is advancing a pipeline of investigational therapies targeting debilitating and life-threatening diseases, with a primary focus on oncology and neuroscience. The company was the first in its field to advance an investigational drug through a pivotal trial and submit a New Drug Application to U.S. regulators.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - ARVINAS, INC. (0001655759) (Filer) | 2026-05-12 | English | |
| 8-K - ARVINAS, INC. (0001655759) (Filer) | 2026-05-12 | English | |
| 10-Q - ARVINAS, INC. (0001655759) (Filer) | 2026-05-11 | English | |
| 8-K - ARVINAS, INC. (0001655759) (Filer) | 2026-05-01 | English | |
| ARS - ARVINAS, INC. (0001655759) (Filer) | 2026-04-29 | English | |
| DEF 14A - ARVINAS, INC. (0001655759) (Filer) | 2026-04-29 | English |
Browse filings by year
10 yearsMarket data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ARVINAS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32625/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32625 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32625 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32625 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32625}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ARVINAS, INC. (id: 32625)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.